Cabot Corporation $CBT Stock Position Raised by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Cabot Corporation (NYSE:CBT) by 16.4% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 110,259 shares of the specialty chemicals company’s stock after purchasing an additional 15,561 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Cabot were worth $10,014,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Hsbc Holdings PLC grew its holdings in shares of Cabot by 495.9% during the second quarter. Hsbc Holdings PLC now owns 18,575 shares of the specialty chemicals company’s stock valued at $1,690,000 after buying an additional 15,458 shares in the last quarter. Empowered Funds LLC purchased a new stake in Cabot in the 2nd quarter worth about $3,147,000. United Capital Financial Advisors LLC acquired a new stake in Cabot during the 2nd quarter worth about $590,000. Equitable Holdings Inc. acquired a new stake in Cabot during the 2nd quarter worth about $499,000. Finally, Jefferies Financial Group Inc. purchased a new position in Cabot during the 2nd quarter valued at about $383,000. 93.18% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Cabot news, CEO Sean Keohane sold 134,895 shares of the firm’s stock in a transaction dated Friday, August 28th. The stock was sold at an average price of $85.00, for a total transaction of $11,466,075.00. Following the transaction, the chief executive officer directly owned 404,134 shares in the company, valued at $34,351,390. This trade represents a 25.03% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders have sold 229,597 shares of company stock worth $19,646,746 over the last 90 days. Corporate insiders own 3.08% of the company’s stock.

Cabot Price Performance

Shares of CBT opened at $81.47 on Monday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.97 and a current ratio of 1.47. The firm has a market cap of $4.21 billion, a PE ratio of 22.95, a PEG ratio of 10.70 and a beta of 0.83. The firm’s 50 day moving average price is $86.67 and its 200 day moving average price is $81.44. Cabot Corporation has a twelve month low of $58.33 and a twelve month high of $94.53.

Cabot (NYSE:CBT) last posted its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 EPS for the quarter, topping the consensus estimate of $1.66 by $0.01. Cabot had a net margin of 5.23% and a return on equity of 20.29%. The company had revenue of $982.00 million during the quarter, compared to the consensus estimate of $943.16 million. During the same period in the previous year, the firm posted $1.90 earnings per share. The company’s revenue for the quarter was up 6.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, research analysts expect that Cabot Corporation will post 6.35 EPS for the current fiscal year.

Cabot Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 28th will be issued a $0.4725 dividend. The ex-dividend date is Friday, August 28th. This represents a $1.89 dividend on an annualized basis and a yield of 2.3%. Cabot’s dividend payout ratio is currently 53.24%.

Analyst Ratings Changes

A number of brokerages have recently weighed in on CBT. Mizuho upped their target price on Cabot from $80.00 to $90.00 and gave the company a “neutral” rating in a report on Thursday, June 25th. JPMorgan Chase & Co. boosted their price objective on shares of Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a research report on Friday, August 7th. UBS Group dropped their price objective on shares of Cabot from $97.00 to $92.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 5th. Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a research report on Friday, August 21st. Finally, Wall Street Zen upgraded shares of Cabot from a “hold” rating to a “buy” rating in a report on Sunday, August 9th. Two research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Cabot has an average rating of “Hold” and an average target price of $89.00.

Cabot Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.